This is a trial with 4 ppl, non blinded, it could just be the placebo effect and this has actually been increasing with time. Maybe people expect drugs to be more effective these days.
The updrs has a lot of self reported answers and then the rest are evaluated by the clinician so lots of room for sub-conscious biases.
Just being in a clinical trial can improve patient's treatment and psychological well-being, its why oncology patients do better in clinical trials.
The cross over component is good for the phase 2b trial but for global penetration they would still need a further phase 3 trial.
Anyone know if they have started implanting patients yet?
Ann: NTCELL demonstrates continued reversal of Parkinsons-LCT.AX, page-59
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 6044404 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1428165 | 3 |
View Market Depth
| Last trade - 16.12pm 14/10/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |
Day chart unavailable